Latus Bio

About:

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.

Website: https://www.latusbio.com

Top Investors: Gaingels, 8VC, The Children's Hospital of Philadelphia, Modi Ventures, Ben Franklin Technology Partners

Description:

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.

Total Funding Amount:

$54M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)latusbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-05-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai